Amended in Assembly June 27, 2016

Amended in Assembly June 14, 2016

Amended in Senate April 19, 2016

Amended in Senate March 28, 2016

Senate BillNo. 1229


Introduced by Senators Jackson and Stone

February 18, 2016


An act to add Section 1714.24 to the Civil Code, relating to pharmaceutical waste.

LEGISLATIVE COUNSEL’S DIGEST

SB 1229, as amended, Jackson. Home-generated pharmaceutical waste: secure drug take-back bins.

Under existing law, the Medical Waste Management Act, the State Department of Public Health regulates the management and handling of medical waste, including pharmaceutical waste, as defined. The act generally prohibits a person from transporting, storing, treating, disposing, or causing the treatment of medical waste in a manner not authorized by the act. A violation of that provision is a crime.

Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter, has willfully or by want of ordinary care, brought the injury upon himself or herself.

This bill would provide that a collector, as defined, is not liable for civil damages, or subject to criminal prosecution, forbegin insert any injury or harm that results from the collectorend insert maintaining a secure drug take-back bin on its premisesbegin delete ifend deletebegin insert provided thatend insert the collector, not for compensation, acts in good faith to take specified steps, including that the collector regularly inspects the area surrounding the secure drug take-back bin for potential tampering or diversion, to ensure the health and safety of consumers and employees and the proper disposal in the waste stream of home-generated pharmaceutical waste, as defined, contained in the bins.

Vote: majority. Appropriation: no. Fiscal committee: no. State-mandated local program: no.

The people of the State of California do enact as follows:

P2    1

SECTION 1.  

(a) The Legislature finds and declares the
2following:

3(1) On October 12, 2010, the federal Secure and Responsible
4Drug Disposal Act of 2010 (Public Law 111-273; hereafter referred
5to as the Disposal Act) was enacted. Before the Disposal Act,
6individuals who wanted to dispose of unused, unwanted, or expired
7pharmaceutical controlled substances had limited disposal options.
8The federal Controlled Substances Act (21 U.S.C. Sec. 801 et seq.;
9hereafter referred to as the CSA) only permitted individuals to
10destroy those substances themselves (e.g., by flushing or
11discarding), surrender them to law enforcement, or seek assistance
12from the federal Drug Enforcement Administration (DEA). These
13restrictions resulted in the accumulation of pharmaceutical
14controlled substances in household medicine cabinets that were
15available for abuse, misuse, diversion, and accidental ingestion.
16The Disposal Act amended the CSA to authorize specified
17individuals, referred to as “ultimate users,” to deliver their
18pharmaceutical controlled substances to another person for the
19purpose of disposal in accordance with regulations promulgated
20by the United States Attorney General.

21(2) On September 9, 2014, the DEA issued its final rule
22governing the secure disposal of controlled substances by
23registrants and ultimate users. Those regulations implement the
24Disposal Act by expanding the options available to collect
25controlled substances from ultimate users for the purpose of
26disposal, including take-back events, mail-back programs, and
27collection receptacle locations. Those regulations, among other
28things, allow authorized manufacturers, distributors, reverse
29distributors, narcotic treatment programs, hospitals/clinics with
P3    1an onsite pharmacy, and retail pharmacies to voluntarily administer
2mail-back programs and maintain collection receptacles.

3(b) It is the intent of the Legislature, with the enactment of this
4act, to do both of the following:

5(1) Encourage the good faith participation of federally authorized
6entities to maintain secure drug take-back bins on their premises
7for the convenience and public health and safety of prescription
8drug consumers and the proper disposal in the waste stream of the
9pharmaceutical waste contained in the bins.

10(2) Limit the civil and criminal liability of participating entities
11that meet certain minimum standards and take reasonable care to
12ensure the health and safety of consumers and employees when
13maintaining secure drug take-back bins on their premises.

14(c) The terms and conditions provided by subdivision (b) of
15Section 1714.24 of the Civil Code, as added by this act, shall be
16construed in a manner consistent with the requirements imposed
17by the DEA’s final rule governing the secure disposal of controlled
18substances (79 Fed. Reg. 53519-70 (September 9, 2014)) and any
19regulations promulgated by the state.

20

SEC. 2.  

Section 1714.24 is added to the Civil Code, to read:

21

1714.24.  

(a) For purposes of this section, the following
22definitions shall apply:

23(1) “Collector” includes only those entities authorized by and
24registered with the federal Drug Enforcement Administration to
25receive a controlled substance for the purpose of destruction, if
26the entity is in good standing with any applicable licensing
27authority.

28(2) “Compensation” means reimbursement or funds received
29from a customer to compensate for the cost incurred in obtaining,
30installing, or maintaining a secure drug take-back bin.
31“Compensation” does not include reimbursement or funds received
32from any other person or entity, other than a customer, to
33compensate for the costs incurred in obtaining, installing, or
34maintaining a secure drug take-back bin.

35(3) “Home-generated pharmaceutical waste” means a
36pharmaceutical that is no longer wanted or needed by the consumer
37and includes any delivery system, such as pills, liquids, and
38inhalers.

P4    1(4) “Maintains” includes owning, leasing, operating, or
2otherwise hosting a secure drug take-back bin on the collector’s
3premises.

4(5) “Pharmaceutical” means a prescription or over-the-counter
5human or veterinary drug, including, but not limited to, a drug as
6defined in Section 109925 of the Health and Safety Code and
7Section 321(g)(1) of Title 21 of the United States Code.
8“Pharmaceutical” includes controlled substances included in
9Schedule II, III, IV, or V of the California Uniform Controlled
10Substances Act (Division 10 (commencing with Section 11000)
11of the Health and Safety Code), but does not include a controlled
12substance included in Schedule I.

13(6) “Secure drug take-back bin” means a collection receptacle
14as described in Section 1317.75 of Title 21 of the Code of Federal
15Regulations.

16(b) Any collector that maintains a secure drug take-back bin
17shall not be liable in a civil action, or be subject to criminal
18prosecution, forbegin insert any injury or harm that results from the collectorend insert
19 maintaining a secure drug take-back bin on its premisesbegin delete ifend deletebegin insert provided
20thatend insert
the collector, not for compensation, acts in good faith to take
21all of the following steps to ensure the health and safety of
22consumers and employees and the proper disposal in the waste
23stream of the home-generated pharmaceutical waste contained in
24a secure drug take-backbegin delete bin:end deletebegin insert bin, unless the injury or harm results
25from the collector’s gross negligence or willful and wanton
26misconduct:end insert

27(1) Complies with all applicable state and federal laws and
28regulations relating to the collection of home-generated
29pharmaceutical waste for disposal in secure drug take-back bins,
30including, but not limited to, the federal Secure and Responsible
31Drug Disposal Act of 2010 (Public Law 111-273).

32(2) Notifies local law enforcement and any local environmental
33health department as to the existence and location of any secure
34drug take-back bin on the collector’s premises and the status of
35the collector’s registration as a collector with the federal Drug
36Enforcement Administration.

37(3) Ensures that the secure drug take-back bin is placed in a
38location that is regularly monitored by employees of the registered
39collector.

P5    1(4) Ensures that conspicuous signage is posted on the secure
2drug take-back bin that clearly notifies customers as to what
3controlled and noncontrolled substances are and are not acceptable
4for deposit into the bin, as well as the hours during which collection
5is allowed.

6(5) Ensures that public access to the secure drug take-back bin
7is limited to hours in which employees of the registered collector
8are present and able to monitor the operation of the secure drug
9take-back bin.

10(6) Regularly inspects the area surrounding the secure drug
11 take-back bin for potential tampering or diversion. Record logs of
12those inspections shall be maintained and retained for two years,
13reflecting the date and time of the inspection, and the initials of
14the employee inspecting the area. The logs shall be maintained in
15writing or electronically and may be combined with logs required
16by state or federal regulations. The logs may be used to demonstrate
17regular inspection of the area. Other records or reports mandated
18by federal or state regulations shall also be retained for a minimum
19of two years unless regulations mandate a longer period.

20(7) Notifies local law enforcement authorities of any suspected
21or known tampering, theft, or significant loss of controlled
22substances, within one business day of discovery. If the collector
23maintains daily business hours, this notification shall be made
24within one calendar day.

25(8) Notify local law enforcement as to any decision to
26discontinue its voluntary collection of controlled substances and
27provide documentation of its written notification to the federal
28Drug Enforcement Administration’s Registration Unit as otherwise
29required under federal laws and regulations.

begin delete

30(c) The protection specified in subdivision (b) shall not apply
31in a case of personal injury or wrongful death that results from the
32collector’s gross negligence or willful or wanton misconduct in
33maintaining a secure drug take-back bin.

end delete
begin delete

34(d)

end delete

35begin insert(end insertbegin insertc)end insert Nothing in this section shall be construed to require entities
36that may qualify as a collector to acquire, maintain, or make
37available to the public a secure drug take-back bin on its premises.



O

    95